Gujarat Alkalies and Chemicals Ltd. (GACL)

Standalone Revenue (FY 2025-26): ₹4,358.08 crore
Consolidated PAT (FY 2025-26): ₹-2.41 crore

Reader Takeaway: Strong standalone growth and dividend payout offset by consolidated JV losses.

What just happened

Gujarat Alkalies and Chemicals Ltd. (GACL) has announced its audited financial results for the fiscal year 2025-26. The company reported a standalone revenue of ₹4,358.08 crore, marking a 7.00% increase from ₹4,072.91 crore in the previous fiscal year. Standalone profit after tax (PAT) saw a significant jump of 31.73% to ₹20.84 crore.

Additionally, the company's board has recommended a dividend of ₹17.70 per share (177%). In a strategic move, GACL approved the setup of a 5000 TPA High Purity Grade Hydrogen Peroxide plant at Dahej, Gujarat, with an estimated investment of ₹67 crore. This plant aims to cater to the semiconductor and electronics industries and is expected to add approximately ₹42 crore to annual sales upon commissioning.

Why this matters

The strong standalone financial performance indicates healthy growth in GACL's core operations. The proposed dividend offers a direct financial return to shareholders. The new Hydrogen Peroxide plant signifies diversification into higher-margin, specialized markets. However, consolidated performance remains a concern, with a net loss of ₹2.41 crore reported, primarily due to losses from the GACL-NALCO joint venture.

The backstory

GACL is a key player in the chemical industry, known for producing caustic soda, chlorine, and allied chemicals. The company has been focusing on increasing its renewable energy share, which rose to 35.7% in FY26. It is also undertaking a digital transformation, migrating to SAP S/4HANA. The GACL-NALCO joint venture, established for specific projects, has been a persistent drag on consolidated profitability.

What changes now

The approval of the Hydrogen Peroxide plant signals a new growth avenue. Management plans further project commissioning in FY 2026-27, including HCl Synthesis Unit, Chlorotoluene Down Stream Plant, Caustic Soda Flaking Plant, and additional renewable energy projects (138.60 MW). These initiatives are expected to improve both top and bottom lines in the coming fiscal year.

Risks to watch

The primary risk highlighted is the continued losses from the GACL-NALCO joint venture, which are impacting the consolidated financial results. Investors will need to monitor how effectively these JV losses are managed or mitigated. Execution risks associated with the new plant and other upcoming projects also need to be considered.

Peer comparison

While specific peer financials for FY26 are not detailed here, GACL operates in the competitive chlor-alkali and specialty chemicals sector. Competitors include companies like Reliance Industries, DCM Shriram, and Grasim Industries, which also have significant chemical operations and are investing in expansion and diversification.

Context metrics (time-bound)

• Standalone Revenue: Increased by 7.00% from FY25 to FY26.
• Standalone Profit before tax: Increased by 352.37% from FY25 to FY26.
• Standalone Profit after tax: Increased by 31.73% from FY25 to FY26.
• Renewable Energy Share: Increased to 35.7% in FY26 from 29.7% in FY25.
• Consolidated PAT: Reported a loss of ₹2.41 crore in FY26.
• GACL-NALCO JV Losses: ₹38.69 crore in FY26.

What to track next

Investors should closely track the progress and commissioning of the new Hydrogen Peroxide plant and other announced projects. Monitoring the financial performance of the GACL-NALCO joint venture and its impact on consolidated results will be crucial. The company's progress on its renewable energy targets and digitization strategy will also be key areas to watch.